Welcome to Inventiva Pharma

No front page content has been created yet.


Latest News

Inventiva announces two appointments to its management team ahead of future key development milestones
Inventiva Announces Last Visit by Last Patient in its Phase IIb SSc Trial and Second Positive DSMB Review in its Phase IIb NASH Trial with Lanifibranor
Inventiva to Participate in the “ROTH Battle of the NASH Thrones Investor Conference”